Patent details

Basic Information

Publication number:

EP2173378

PCT Application Number:

PCT/US/2008/008084

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP087798559

PCT Publication Number:

WO/2009/002562

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMPLEXES OF IL-15 AND IL-15RALPHA AND USES THEREOF

French Title of Invention:

COMPLEXES D'IL-15 ET IL-15R ALPHA ET LEURS UTILISATIONS

German Title of Invention:

KOMPLEXE VON IL-15 UND IL-15RALPHA UND IHRE VERWENDUNGEN

SPC Number:

Dates

Filing date:

27/06/2008

Grant date:

19/03/2014

EP Publication Date:

19/03/2014

PCT Publication Date:

31/12/2008

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

14/04/2010

EP B1 Publication Date:

19/03/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

27/06/2014

Expiration date:

27/06/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

27/06/2008

 

 

Name:

Admune Therapeutics LLC

Address:

107 Water Street, Danvers, MA 01923, United States (US)

Name:

The United States Of America,As Represented By The

Address:

Office Of Technology Transfer National Institute Of Health, Bethesda, MD 20892-7660, United States (US)

Inventor

1

Name:

PAVLAKIS George, N.

Address:

United States (US)

2

Name:

FINKIELSZTEIN Sergio

Address:

United States (US)

3

Name:

FELBER Barbara, K.

Address:

United States (US)

4

Name:

VOURNAKIS John, N.

Address:

United States (US)

Priority

Priority Number:

937471 P

Priority Date:

27/06/2007

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 39/395;

Filing date	Document type	Number of pages